Roche Holding AG
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Roche Holding AG in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Roche Holding AG.
Recent articles on PMLiVE featuring Roche Holding AG
The study showed the drug reduced serious adverse events and hospitalisations
Opioid liability issue overshadowed the company’s Q3 results
Demonstrates efficacy as a preventative treatment
Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis
Vertex resisting real-world data proposal
First novel treatment in decades, but hasn’t shown superiority to Tamiflu
Trial looks at benefts in high risk groups
Biotech sees 9% growth ahead of potential landmark announcement
A round-up from pharma, biotech and healthcare
Dan Coffin joins the London headquarters as Director
Former CEO Dr John Clarkson will move into an executive chairman position
US biotech points to new analysis of phase III results for tramiprosate
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology